Cupric Arsenite, Copper, Potassium Phosphate, Dibasic, Lactic Acid, L-,Magnesium Phosphate, Tribasic, Pentahydrate
FDA Drug Information • Also known as: Leg Cramps Relief
- Brand Names
- Leg Cramps Relief
- Drug Class
- Copper-containing Intrauterine Device [EPC]
- Route
- SUBLINGUAL
- Dosage Form
- PELLET
- Product Type
- HUMAN OTC DRUG
What Is Cupric Arsenite, Copper, Potassium Phosphate, Dibasic, Lactic Acid, L-,Magnesium Phosphate, Tribasic, Pentahydrate Used For?
Indications & Usage: Temporarily relieves muscle pains, spasms and cramps in calves, feet & legs. Night cramps & pain of the lower limbs.
Dosage and Administration
Dosage and Administration: Turn tube upside down, twist cap to break seal & release pellets. Using clear cap, place 3 pellets to dissolve under your tongue 3 times a day or as needed. Take apart from food or drinks. To preserve purity avoid touching pellets with fingers.
Warnings and Precautions
Warnings: If symptoms persist or worsen, or if pregnant or nursing, consult a doctor. Keep out of reach of children. Do not use if cap seal is broken or missing.
About This Information
This drug information is sourced from FDA-approved labeling via the openFDA database. It is intended for educational and reference purposes only. This is not medical advice. Always consult your healthcare provider before making decisions about medication. Drug information may be updated by the FDA; check with your pharmacist for the most current information.
What are side effects?
Side effects are unwanted reactions that can occur when taking a medication. They range from mild (headache, nausea) to severe (allergic reactions, organ damage). Not everyone experiences side effects, and severity varies. Report any concerning side effects to your doctor.
What are drug interactions?
Drug interactions occur when a medication is affected by another drug, food, or supplement. Interactions can make medications less effective or cause dangerous side effects. Always tell your doctor about all medications and supplements you take.